Insulet (PODD) free cash flow

Free cash flow · fiscal 2025
$349.90M

Insulet (PODD) generated free cash flow of $349.90M in fiscal 2025 (the year ended December 31, 2025). That is 18.1% higher than the $296.20M of fiscal 2024. Figures as of 18 Nov 2026, 12:15 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$349.90M
Change on fiscal 2024
+18.1%
Highest on record
$349.90Mfiscal 2025
Lowest on record
-$180.00Mfiscal 2021
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Insulet free cash flow, in more detail

Across the 17 fiscal years on record (2009–2025), the highest was $349.90M in fiscal 2025 and the lowest -$180.00M in fiscal 2021.

History · 17 fiscal years

Free cash flow by fiscal year

Insulet free cash flow, year by year

Insulet (PODD) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$349.90M 18.1% up
2024$296.20M 711.5% up
2023$36.50M—
2022-$38.30M—
2021-$180.00M—
2020-$45.00M—
2019-$65.30M—
2018-$121.50M—
2017-$32.50M—
2016-$6.20M—
2015-$23.16M—
2014-$2.57M—
2013-$3.96M—
2012-$40.05M—
2011-$36.57M—
2010-$42.17M—
2009-$52.46M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Insulet and comparable companies
CompanyFree cash flowFiscal year
Spyre Therapeutics SYRE-$169.25M2025
Qiagen QGEN$447.20M2025
Insulet PODD$349.90M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PODD

Insulet, figure by figure

Insulet (PODD) overview: price, valuation and scorecardAll health care companies by market value

Insulet free cash flow: questions and answers

What is Insulet's free cash flow?

Insulet (PODD) generated free cash flow of $349.90M in fiscal 2025 (the year ended December 31, 2025). That is 18.1% higher than the $296.20M of fiscal 2024.

What are the highest and lowest free cash flow figures on record for Insulet?

Across the 17 fiscal years on record (2009–2025), the highest was $349.90M in fiscal 2025 and the lowest -$180.00M in fiscal 2021.

How is Insulet's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Insulet it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Insulet (PODD) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/PODD/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.